Mutations in isocitrate dehydrogenase (IDH)-1 or-2 are found in the majority of WHO grade II and III astrocytomas and oligodendrogliomas, and secondary glioblastomas (Parsons et al., 2008; Yan et al., 2009). Here, IDH1 is linked to glioblastoma.